This Unstoppable ETF Could Turn $100 per Month Into $40,000 With Next to No Effort on Your Part. Here's How.

The real market mechanism here is not “small fee savings,” it’s asset-gathering for a wrapper that is optimized for long-duration, low-touch capital. Over 10+ years, a few basis points matter, but only if the product becomes the default destination for recurring contributions; otherwise the spread is too small to force meaningful rotation out of the incumbent. That makes IVZ the only direct equity beneficiary, and even then it is a slow AUM compounding story rather than a near-term earnings catalyst.

The bigger second-order effect is that every incremental dollar into Nasdaq-100 products reinforces concentration in the same mega-cap names already doing the heavy lifting. That creates a mild bid for NVDA and other top-weight constituents, but the effect is mechanical and diffuse, not a fundamental re-rating event. In practice, the competitive loser is any higher-fee growth exposure without either better liquidity or differentiated factor exposure; passive implementation keeps winning share from active products.

Contrarian view: the market tends to overestimate fee sensitivity and underestimate trading frictions. QQQ still owns the options market, institutional familiarity, and intraday liquidity, which matter more than 3 bps for most non-retail capital. This is only actionable if we see sustained net inflows into QQQM over the next 1-2 quarters; if those flows stall, the thesis collapses and the fee edge becomes irrelevant versus a broad Nasdaq de-rating from rates or AI disappointment.